Variation in cytokine genes can contribute to severity of acetabular osteolysis and risk for revision in patients with ABG 1 total hip arthroplasty: A genetic association study

BMC Medical Genetics

Volumn 10, Issue , 2009, Pages 109-

  Gallo, Jiri ^a   Mrazek, Frantisek ^a   Petrek, Martin ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR ALPHA; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ACETABULUM OSTEOLYSIS; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE LOCATION; GENETIC ASSOCIATION; HETEROZYGOTE; HIP DISEASE; HUMAN; MAJOR CLINICAL STUDY; REOPERATION; SINGLE NUCLEOTIDE POLYMORPHISM; SURGICAL RISK; TOTAL HIP PROSTHESIS;

EID: 70549098126     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-10-109     Document Type: Article

References (52)

1. Learmonth ID, Young C, Rorabeck C. The operation of the century: total hip replacement. Lancet 2007, 370(9597):1508-1519. 10.1016/S0140-6736(07)60457-7, 17964352.
2. Tuan RS, Lee FY, Y TK, Wilkinson JM, Smith RL. What are the local and systemic biologic reactions and mediators to wear debris, and what host factors determine or modulate the biologic response to wear particles?. J Am Acad Orthop Surg 2008, 16(Suppl 1):S42-48. 2714366, 18612013.
3. Konttinen YT, Zhao D, Beklen A, Ma G, Takagi M, Kivela-Rajamaki M, Ashammakhi N, Santavirta S. The microenvironment around total hip replacement prostheses. Clin Orthop Relat Res 2005, (430):28-38. 10.1097/01.blo.0000150451.50452.da, 15662301.
4. Vermes C, Chandrasekaran R, Jacobs JJ, Galante JO, Roebuck KA, Glant TT. The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts. J Bone Joint Surg Am 2001, 83-A(2):201-211.
5. Koulouvaris P, Ly K, Ivashkiv LB, Bostrom MP, Nestor BJ, Sculco TP, Purdue PE. Expression profiling reveals alternative macrophage activation and impaired osteogenesis in periprosthetic osteolysis. J Orthop Res 2008, 26(1):106-116. 10.1002/jor.20486, 17729302.
6. Shanbhag AS, Kaufman AM, Hayata K, Rubash HE. Assessing osteolysis with use of high-throughput protein chips. J Bone Joint Surg Am 2007, 89(5):1081-1089. 10.2106/JBJS.F.00330, 17473147.
7. Sabokbar A, Itonaga I, Sun SG, Kudo O, Athanasou NA. Arthroplasty membrane-derived fibroblasts directly induce osteoclast formation and osteolysis in aseptic loosening. J Orthop Res 2005, 23(3):511-519. 10.1016/j.orthres.2004.10.006, 15885469.
8. Tunyogi-Csapo M, Kis-Toth K, Radacs M, Farkas B, Jacobs JJ, Finnegan A, Mikecz K, Glant TT. Cytokine-controlled RANKL and osteoprotegerin expression by human and mouse synovial fibroblasts: Fibroblast-mediated pathologic bone resorption. Arthritis Rheum 2008, 58(8):2397-2408. 10.1002/art.23653, 18668542.
9. Ramage SC, Urban NH, Jiranek WA, Maiti A, Beckman MJ. Expression of RANKL in osteolytic membranes: association with fibroblastic cell markers. J Bone Joint Surg Am 2007, 89(4):841-848. 10.2106/JBJS.F.00655, 17403809.
10. Wilkinson JM, Hamer AJ, Stockley I, Eastell R. Polyethylene wear rate and osteolysis: critical threshold versus continuous dose-response relationship. J Orthop Res 2005, 23(3):520-525. 10.1016/j.orthres.2004.11.005, 15885470.
11. Goodman SB. Wear particles, periprosthetic osteolysis and the immune system. Biomaterials 2007, 28(34):5044-5048. 10.1016/j.biomaterials.2007.06.035, 2065897, 17645943.
12. Granchi D, Cenni E, Trisolino G, Giunti A, Baldini N. Sensitivity to implant materials in patients undergoing total hip replacement. J Biomed Mater Res B Appl Biomater 2006, 77(2):257-264.
13. Ollier WE. Cytokine genes and disease susceptibility. Cytokine 2004, 28(4-5):174-178. 10.1016/j.cyto.2004.07.014, 15588692.
14. Wilkinson JM, Wilson AG, Stockley I, Scott IR, Macdonald DA, Hamer AJ, Duff GW, Eastell R. Variation in the TNF gene promoter and risk of osteolysis after total hip arthroplasty. J Bone Miner Res 2003, 18(11):1995-2001. 10.1359/jbmr.2003.18.11.1995, 14606512.
15. Malik MH, Bayat A, Jury F, Kay PR, Ollier WE. Genetic susceptibility to total hip arthroplasty failure--positive association with mannose-binding lectin. J Arthroplasty 2007, 22(2):265-270. 10.1016/j.arth.2006.02.163, 17275645.
16. Malik MH, Jury F, Bayat A, Ollier WE, Kay PR. Genetic susceptibility to total hip arthroplasty failure: a preliminary study on the influence of matrix metalloproteinase 1, interleukin 6 polymorphisms and vitamin D receptor. Ann Rheum Dis 2007, 66(8):1116-1120. 10.1136/ard.2006.062018, 17363400.
17. Kolundzic R, Orlic D, Trkulja V, Pavelic K, Troselj KG. Single nucleotide polymorphisms in the interleukin-6 gene promoter, tumor necrosis factor-alpha gene promoter, and transforming growth factor-beta1 gene signal sequence as predictors of time to onset of aseptic loosening after total hip arthroplasty: preliminary study. J Orthop Sci 2006, 11(6):592-600. 10.1007/s00776-006-1069-y, 17139467.
18. Malik MH, Bayat A, Jury F, Ollier WE, Kay PR. Genetic susceptibility to hip arthroplasty failure--association with the RANK/OPG pathway. Int Orthop 2006, 30(3):177-181. 10.1007/s00264-006-0074-2, 2532089, 16583245.
19. Gordon A, Southam L, Loughlin J, Wilson AG, Stockley I, Hamer AJ, Eastell R, Wilkinson JM. Variation in the secreted frizzled-related protein-3 gene and risk of osteolysis and heterotopic ossification after total hip arthroplasty. J Orthop Res 2007, 25(12):1665-1670. 10.1002/jor.20446, 17600823.
20. Gordon A, Kiss-Toth E, Stockley I, Eastell R, Wilkinson JM. Polymorphisms in the interleukin-1 receptor antagonist and interleukin-6 genes affect risk of osteolysis in patients with total hip arthroplasty. Arthritis Rheum 2008, 58(10):3157-3165. 10.1002/art.23863, 18821666.
21. Chanock SJ, Manolio T, Boehnke M, Boerwinkle E, Hunter DJ, Thomas G, Hirschhorn JN, Abecasis G, Altshuler D, Bailey-Wilson JE. Replicating genotype-phenotype associations. Nature 2007, 447(7145):655-660. 10.1038/447655a, 17554299.
22. Saleh KJ, Holtzman J, Gafni A, Saleh L, Davis A, Resig S, Gross AE. Reliability and intraoperative validity of preoperative assessment of standardized plain radiographs in predicting bone loss at revision hip surgery. J Bone Joint Surg Am 2001, 83-A(7):1040-1046.
23. Gallo J, Langova K, Havranek V, Cechova I. Poor survival of ABG I hip prosthesis in younger patients. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2008, 152(1):163-168.
24. Engh CA, Massin P, Suthers KE. Roentgenographic assessment of the biologic fixation of porous-surfaced femoral components. Clin Orthop Relat Res 1990, (257):107-128.
25. Udomkiat P, Wan Z, Dorr LD. Comparison of preoperative radiographs and intraoperative findings of fixation of hemispheric porous-coated sockets. J Bone Joint Surg Am 2001, 83-A(12):1865-1870.
26. Gallo J, Havranek V, Zapletalova J, Mandat D. Measurement of acetabular polyethylene wear of total hip replacement, using a universal measuring microscope. Characteristics of measurements. Acta Chir Orthop Traumatol Cech 2006, 73(1):28-33. In Czech.
27. Gallo J, Havranek V, Cechova I, Zapletalova J. Wear measurement of retrieved polyethylene ABG 1 cups by universal-type measuring microscope and X-ray methods. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2006, 150(2):321-326.
28. Javor J, Bucova M, Ferencik S, Grosse-Wilde H, Buc M. Single nucleotide polymorphisms of cytokine genes in the healthy Slovak population. Int J Immunogenet 2007, 34(4):273-280. 10.1111/j.1744-313X.2007.00693.x, 17627763.
29. Kubistova Z, Mrazek F, Tudos Z, Kriegova E, Ambruzova Z, Mytilineos J, Petrek M. Distribution of 22 cytokine gene polymorphisms in the healthy Czech population. Int J Immunogenet 2006, 33(4):261-267. 10.1111/j.1744-313X.2006.00609.x, 16893389.
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16(3):1215. 10.1093/nar/16.3.1215, 334765, 3344216.
31. Hansen JA, . (Ed) Immunobiology of the human MHC. Proceedings of the 13th International Histocompatibility Workshop and Conference 2007, 1. Seattle: IHWG Press.
32. Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, Welsh KI, Du Bois RM, Petrek M. Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2002, 165(2):148-151.
33. Mrazek F, Gallo J, Arakelyan A, Kubistova Z, Petrek M. Single nucleotide polymorphisms in genes for cytokines interleukin (IL)-2, IL-6 and TNFalpha influence severity of osteolysis after total hip arthroplasty. Tissue Antigens 2008, 71(4):331-332.
34. Wroblewski BM, Siney PD, Fleming PA. Charnley low-friction arthroplasty: survival patterns to 38 years. J Bone Joint Surg Br 2007, 89(8):1015-1018. 10.1302/0301-620X.89B8.18387, 17785737.
35. Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, Helm-van Mil AH, Allaart CF, Verduyn W, Houwing-Duistermaat J. A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis. PLoS Med 2007, 4(9):e278. 10.1371/journal.pmed.0040278, 1976626,1976626, 17880261.
36. DeLee JG, Charnley J. Radiological demarcation of cemented sockets in total hip replacement. Clin Orthop Relat Res 1976, (121):20-32.
37. Little J, Higgins JP, Ioannidis JP, Moher D, Gagnon F, von Elm E, Khoury MJ, Cohen B, Davey-Smith G, Grimshaw J. Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement. Hum Genet 2009, 125(2):131-151. 10.1007/s00439-008-0592-7, 19184668.
38. Bayley JP, de Rooij H, Elsen PJ, Huizinga TW, Verweij CL. Functional analysis of linker-scan mutants spanning the -376, -308, -244, and -238 polymorphic sites of the TNF-alpha promoter. Cytokine 2001, 14(6):316-323. 10.1006/cyto.2001.0902, 11497492.
39. Sharma S, Ghosh B, Sharma SK. Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians. Clin Exp Immunol 2008, 151(2):251-259. 2276943, 18062795.
40. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998, 102(7):1369-1376. 10.1172/JCI2629, 508984, 9769329.
41. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000, 275(24):18138-18144. 10.1074/jbc.M000379200, 10747905.
42. Smith AJ, Humphries SE. Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 2009, 20(1):43-59. 10.1016/j.cytogfr.2008.11.006, 19038572.
43. Schluter B, Raufhake C, Erren M, Schotte H, Kipp F, Rust S, Van Aken H, Assmann G, Berendes E. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 2002, 30(1):32-37. 10.1097/00003246-200201000-00005, 11902285.
44. Michalek J, Svetlikova P, Fedora M, Klimovic M, Klapacova L, Bartosova D, Hrstkova H, Hubacek JA. Interleukin-6 gene variants and the risk of sepsis development in children. Hum Immunol 2007, 68(9):756-760. 10.1016/j.humimm.2007.06.003, 17869650.
45. Campos MI, Godoy dos Santos MC, Trevilatto PC, Scarel-Caminaga RM, Bezerra FJ, Line SR. Interleukin-2 and interleukin-6 gene promoter polymorphisms, and early failure of dental implants. Implant Dent 2005, 14(4):391-396.
46. Zaiss MM, Axmann R, Zwerina J, Polzer K, Guckel E, Skapenko A, Schulze-Koops H, Horwood N, Cope A, Schett G. Treg cells suppress osteoclast formation: A new link between the immune system and bone. Arthritis Rheum 2007, 56(12):4104-4112. 10.1002/art.23138, 18050211.
47. Matesanz F, Fedetz M, Leyva L, Delgado C, Fernandez O, Alcina A. Effects of the multiple sclerosis associated -330 promoter polymorphism in IL2 allelic expression. J Neuroimmunol 2004, 148(1-2):212-217. 10.1016/j.jneuroim.2003.12.001, 14975604.
48. Hoffmann SC, Stanley EM, Darrin Cox E, Craighead N, DiMercurio BS, Koziol DE, Harlan DM, Kirk AD, Blair PJ. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation 2001, 72(8):1444-1450. 10.1097/00007890-200110270-00019, 11685118.
49. Scola L, Candore G, Colonna-Romano G, Crivello A, Forte GI, Paolisso G, Franceschi C, Lio D, Caruso C. Study of the association with -330T/G IL-2 in a population of centenarians from centre and south Italy. Biogerontology 2005, 6(6):425-429. 10.1007/s10522-005-4909-9, 16518704.
50. Dupuis J, O'Donnell CJ. Interpreting results of large-scale genetic association studies: separating gold from fool's gold. JAMA 2007, 297(5):529-531. 10.1001/jama.297.5.529, 17284705.
51. Ioannidis JP. Why most published research findings are false. PLoS Med 2005, 2(8):e124. 10.1371/journal.pmed.0020124, 1182327,1182327, 16060722.
52. Chougle A, Hemmady MV, Hodgkinson JP. Severity of hip dysplasia and loosening of the socket in cemented total hip replacement. A long-term follow-up. J Bone Joint Surg Br 2005, 87(1):16-20.